Saidu Sani et al.
Temozolomide-Acquired Resistance Is Associated with Modulation of the Integrin Repertoire in Glioblastoma, Impact of α5β1 Integrin
Cancers 2022, vol. 14, issue 2
doi: 10.3390/cancers14020369